Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™
ABIM Diplomates - maximum of 0.25 ABIM MOC points
Nurses - 0.25 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)
Physician Assistant - 0.25 AAPA hour(s) of Category I credit
IPCE - 0.25 Interprofessional Continuing Education (IPCE) credit
This activity is intended for primary care physicians, neurologists, nurses/nurse practitioners, physician assistants, and other members of the healthcare team who treat and manage adults with a history of stroke.
The goal of this activity is for the healthcare team to be better able to evaluate how exercise can affect cognitive function among adults with a history of stroke.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Medscape, LLC designates this enduring material for a maximum of 0.25
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.00 contact hours are in the area of pharmacology.
For Physician Assistants
Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until 12/16/2023. PAs should only claim credit commensurate with the extent of their participation.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of
continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the
time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the
valid credit period that
is noted on the title page. To receive
AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in
your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as
the certificates from the
CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC / CE Released: 12/16/2022
Valid for credit through: 12/16/2023
processing....
Exercise can have a positive effect on cognitive function. A previous meta-analysis by Northey and colleagues, published in the February 2018 issue of the British Journal of Sports Medicine, summarized the results of 39 randomized trials of exercise among adults older than 50 years.
Researchers found moderate-quality evidence that exercise significantly improved cognitive function. Moreover, different forms of exercise, including aerobic exercise, resistance training, multicomponent training, and tai chi, were all associated with improved cognitive outcomes. In contrast, yoga did not affect cognitive function. The research also suggested that exercise was most beneficial to cognition when it was at least moderate intensity and lasted at least 45 minutes per session.
Patients with stroke are at high risk for cognitive decline. A new randomized trial examines the potential benefit of exercise on their cognitive function.
Results of a new proof-of-concept trial suggest that exercise had a positive effect on cognitive domains specifically affected by stroke, including memory, attention, and executive function.
The results indicate that exercise is not only physically beneficial but also has a clinically important effect on cognition in patients who have had a stroke, study investigator Teresa Liu-Ambrose, PhD, PT, associate professor and Canada Research Chair in Physical Activity, Faculty of Medicine, University of British Columbia, Vancouver, Canada, told Medscape Medical News.
"At the start of our trial, subjects had at least mild to moderate cognitive impairment, and after 6 months of training, those in the exercise group, on average, were reverting to what would be seen more as a normal state of cognition," she added.
The findings were published online October 13 in JAMA Network Open.[2]
First Study to Target CognitionResearch shows that stroke doubles dementia risk, but poststroke rehabilitation tends to focus on improving motor function rather than cognition, said Dr Liu-Ambrose.
Evidence suggests that exercise is beneficial in patients who have had a stroke, but these studies were not specifically designed to explore the role of exercise, said Dr Liu-Ambrose. "To my knowledge, this new study is the only one directly aimed at cognition."
The new single-center, single-blinded study included 120 community-dwelling patients who had had an ischemic or hemorrhagic stroke. They were a mean age of 70 years, and 62% were men.
The researchers randomly allocated participants to 1 of 3 groups: an exercise training (EX) program that included progressively more difficult strength, aerobic, agility, and balance exercises; a cognitive and social enrichment (ENRICH) group that involved computerized cognitive training and social activities; and a control group that did balance and toning (BAT) exercises.
The 6-month intervention included twice-weekly 60-minute supervised classes. There was then a 6-month follow-up.
The mean baseline Montreal Cognitive Assessment and Alzheimer Disease Assessment Scale-Cognitive-Plus (ADAS-Cog-Plus) scores were 21.89 and 0.22, respectively, indicating cognitive impairment. The mean baseline Fugl-Meyer Assessment Motor score was 81.21, indicating moderate to mild motor impairment.
The primary outcome was the ADAS-Cog-Plus, which assesses memory, attention, and executive function. At the end of the intervention, participants in the EX group had significantly better ADAS-Cog-Plus performance compared with the BAT group (estimated mean difference, −0.24; 95% CI, −0.43 to 0.04; P=.02).
This difference did not persist at the end of follow-up (estimated mean difference, −0.08; 95% CI, −0.29 to 0.12).
Use It or Lose It"It's intuitive and biologically sound to say that if you're not going to continue to do the exercises, the benefits over time will disappear; it's the notion of use it or lose it," said Dr Liu-Ambrose.
There were no cognitive differences between the ENRICH and BAT groups at the end of the intervention or at the end of follow-up. The evidence suggests that people improve only on the computerized training component they train for, and not on other cognitive performance measures, said Dr Liu-Ambrose.
As for secondary outcomes, the BAT group performed significantly better on the 6-minute walk test compared with the ENRICH group at the end of the intervention (estimated mean difference, −25.70 meters; 95% CI, −50.70 to −0.73 meters; P=.04). The BAT group also reported significantly higher physical activity participation outside the study compared with the EX group at the end of the intervention and at the end of follow-up.
Dr Liu-Ambrose noted that the BAT group included fundamental balance exercises, although these were not progressive.
"The takeaway here is that any basic exercise could be beneficial for people in the chronic phase of stroke, and improving some of the most basic motor functions such as balance, etc, could translate to people's capacity and willingness to engage in further physical activity."
The EX group significantly and meaningfully improved in terms of 4-meter gait speed (by 0.16 m/second) and 6-minute walk test (by 68.72 m) during the 6-month intervention.
A post hoc analysis showed that participants in the exercise group improved on the 13-item ADAS-Cog by 5.65 points. A change of 3.0 points on this scale is a minimally significant difference.
Dr Liu-Ambrose noted that such a change could translate into, for example, patients who have had a stroke being able to cook, plan, and remember to take their medication. "It allows them to live independently and with quality."
There were 42 adverse events (19 in the EX group, 2 in the ENRICH group, and 21 in the BAT group), and 35 of these were deemed not related or most likely not related to the study. No events were serious, with many stemming from muscle soreness, said Dr Liu-Ambrose.
The findings reflect the shifting perspective on what is possible during the chronic phase of stroke, said Dr Liu-Ambrose. "In the past, the notion was that once in the chronic phase, you can't reap much gain from intervening, but the evidence now would suggest there's still the potential from a neuroplasticity perspective."
Counterintuitive FindingsCommenting for Medscape Medical News, Robert J. Adams, MD, distinguished professor of neurology, director, South Carolina Stroke Center of Economic Excellence, Department of Neurology, Medical University of South Carolina, Charleston, and an American Stroke Association national volunteer expert, found the results "surprising."
That there was improvement in cognitive function with the physical exercise regimen but not the cognitive and social enrichment intervention "seems counterintuitive and is what makes the report interesting," said Dr Adams.
"It suggests that more attention needs to be paid to this part of therapy."
He noted that the study participants were at least 5 years out from their stroke and had cognitive impairment and moderate physical deficits. "Right now, basically nothing much at all is done--either in the physical, social, or cognitive domains--this long after stroke, for sure not rigorous physical exercise."
The data might support the idea of periodic "booster" programs in the chronic phase after stroke, said Dr Adams.
However, he said, the study "does not provide evidence for an enduring benefit, nor does it reduce the progression from cognitive impairment to dementia."
Dr Liu-Ambrose and Dr Adams have reported no relevant financial relationships.
JAMA Netw Open. Published online October 13, 2022.